有机化学 ›› 2012, Vol. 32 ›› Issue (10): 1908-1918.DOI: 10.6023/cjoc201204016 上一篇    下一篇

研究论文

含有对氨基苯甲酸和苯磺酰胺结构单元的新型分子及其抗糖尿病活性

杨龙a, 晏菊芳b, 范莉a, 陈欣b, 上官瑞燕a, 汪林发a, 杨大成a   

  1. a 西南大学化学化工学院 重庆 400715;
    b 成都地奥制药集团药物筛选中心 成都 610041
  • 收稿日期:2012-04-13 修回日期:2012-05-31 发布日期:2012-10-27
  • 通讯作者: 杨大成 E-mail:hxydc@swu.edu.cn
  • 基金资助:

    重庆市科技攻关计划(Nos. 2011AB5001, 2011AC1053, 2011AC5107)资助项目.

Synthesis and Antidiabetic Activity of Novel Molecules Containing p-Aminobenzoic Acid and Benzenesulfonamide Moiety

Yang Longa, Yan Jufangb, Fan Lia, Chen Xinb, Shangguan Ruiyana, Wang Linfaa, Yang Dachenga   

  1. a School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715;
    b Drug Screening Center, Chengdu Di'Ao Pharmaceutical Group Co., Ltd., Chengdu 610041
  • Received:2012-04-13 Revised:2012-05-31 Published:2012-10-27
  • Supported by:

    Project supported by the Scientific and Technological Project in Chongqing City (Nos. 2011AB5001, 2011AC1053, 2011AC5107).

基于本实验室前期发现的高活性分子的结构特征, 作者设计了含有对氨基苯甲酸和苯磺酰胺结构单元的新型分子. 通过4条合成路线的探索, 发现了中间体IM1IM3及目标分子TM1TM2的简捷合成路线和实用合成方法; 采用本实验室前期建立的合成方法, 顺利得到设计的26个化合物, 合成方法简便, 反应条件温和, 收率为64%~95%. 21个新化合物通过1H NMR,13C NMR和HRMS进行结构表征. 目前的体外抗糖尿病活性结果显示, 所得26个分子的过氧化物酶体增殖物激活受体(PPAR)的激动活性较弱. 本研究进一步证实了醇/二氯亚砜体系脱除脂肪酰芳胺酰基的能力, 有助于含有对氨基苯甲酸和苯磺酰胺结构单元分子的进一步结构优化.

关键词: 糖尿病, 对氨基苯甲酸, 磺胺, 过氧化物酶体增殖物激活受体, 合成, 活性

A new class of target molecules containing p-aminobenzoic acid and benzenesulfonamide moiety is reported, based on the structural features of a series of analogues with strong biological activities previously synthesized by the group. By taking 4 discrete synthetic routes, the practical procedures and facile preparative routes for both the intermediates of IM1IM3 and the target molecules of TM1 and TM2 were established. A total of 26 designed compounds were synthesized smoothly using the established synthetic approaches under mild reaction conditions, with low cost and high yields (64%~95%). The chemical structures of 21 new compounds were confirmed by 1H NMR, 13C NMR and HRMS techniques. The bioassay test demonstrates weak antidiabetic activity for all the target molecules. This study has further expanded the application of alcohol/SOCl2 system in the deacylation of N-arylacetamides and chloro-N-arylacetamides as well as esterification of carboxy group concomitantly, which is supportive to the structure optimization of novel molecules containing p-aminobenzoic acid and benzenesulfonamide moiety.

Key words: diabetes mellitus; p-aminobenzoic acid, sulfanilamide, peroxisome proliferator-activated receptors (PPAR), synthesis, activity